We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improves the lives of patients. Its commercial portfolio comprises two products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder... Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improves the lives of patients. Its commercial portfolio comprises two products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome (SMS) and Fanapt for the treatment of schizophrenia. Its other products include Tradipitant (VLY-686), VTR-297, and VQW-765. Show more
Reminds Vanda’s Board of Their Fiduciary Duties Given the Mishandling of Future Pak’s Offer to Acquire Vanda’s Underperforming and Undervalued Shares at an ~80-90% Premium Expresses Serious...
Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation PR Newswire WASHINGTON, April 22, 2024 WASHINGTON, April 22, 2024 /PRNewswire/ -- Vanda...
Vanda Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan PR Newswire WASHINGTON, April 17, 2024 WASHINGTON, April 17, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. ("Vanda" or the...
Vanda Pharmaceuticals Confirms Rejection of Unsolicited Takeover Proposals from Future Pak PR Newswire WASHINGTON, April 17, 2024 Board Determined Unsolicited Takeover Proposals Significantly...
A Washington D.C.-based biotech is causing quite the stir so far during Wednesday’s premarket after the company’s Fanapt received FDA approval for the acute treatment To read the full...
Vanda Pharmaceuticals' Fanapt® (iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I Disorder PR Newswire WASHINGTON, April 2, 2024 Fanapt® Treatment is Now Available to...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.34 | -6.85483870968 | 4.96 | 5.3 | 4.43 | 1660856 | 4.78533429 | CS |
4 | 0.39 | 9.21985815603 | 4.23 | 6.03 | 3.87 | 5487012 | 4.98318031 | CS |
12 | 0.93 | 25.2032520325 | 3.69 | 6.03 | 3.46 | 2446800 | 4.74309162 | CS |
26 | 0.34 | 7.94392523364 | 4.28 | 6.03 | 3.295 | 1635729 | 4.47870049 | CS |
52 | -1.63 | -26.08 | 6.25 | 7 | 3.295 | 1267925 | 4.76745825 | CS |
156 | -12.48 | -72.9824561404 | 17.1 | 21.8627 | 3.295 | 756605 | 8.03182813 | CS |
260 | -12 | -72.202166065 | 16.62 | 21.8627 | 3.295 | 694507 | 9.86379919 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions